(Q43465644)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

0 references

1 reference

1 September 2023

1 reference

1 September 2023

author name string

A. Keong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225510

1 September 2023

A. R. Rabson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225510

1 September 2023

language of work or name

1 reference

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

http://link.springer.com/content/pdf/10.1007/BF00199161.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00199161/fulltext.html

1 September 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00199161

1 September 2023

1 reference

Cancer Immunology, Immunotherapy

1 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

178-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225510%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

29 October 2019

PLC/PRF/5

0 references

cites work

Immunoregulatory properties of human esophageal tumor extract

1 reference

12 December 2020

Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells.

1 reference

12 December 2020

Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts

1 reference

12 December 2020

Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours

1 reference

12 December 2020

Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro

1 reference

12 December 2020

Blocking factors in sera of breast cancer patients

1 reference

12 December 2020

Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) depresses natural killer (NK) cell activity

1 reference

12 December 2020

Serum-mediated immunosuppression in lung cancer

1 reference

12 December 2020

Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer

1 reference

12 December 2020

An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture

1 reference

12 December 2020

Immunoregulatory factors derived from human tumors. I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferative and cytotoxic responses in vitro

1 reference

12 December 2020

Immunosuppression and the Role of Suppressive Factors in Cancer

1 reference

12 December 2020

Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity

1 reference

12 December 2020